Lista de obras -

A 3-year follow-up study of radiotherapy using computed tomography-based image-guided brachytherapy for cervical cancer

scholarly article by Atsushi Kawashima et al published 1 March 2019 in Journal of Radiation Research

A case of complete hydatidiform mole with coexistent fetus: conclusive diagnosis of androgenesis of the molar placenta by variation of paternal acrocentric short arms

scientific article published on 19 June 2009

A case of laparoscopic surgery for endometrial cancer in a patient previously treated with a transvaginal mesh procedure for pelvic organ prolapse

scientific article published on 15 April 2017

A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)

artículo científico publicado en 2018

A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy

scientific article published on 04 January 2019

Balloon tamponade during cesarean section is useful for severe post‐partum hemorrhage due to placenta previa ⬇️

artículo científico publicado el 10 de agosto de 2011

Cervical insufficiency following cesarean delivery after prolonged second stage of labor: experiences of two cases

article by Shinsuke Koyama et al published April 2010 in Journal of Obstetrics and Gynaecology Research

Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).

artículo científico publicado en 2017

Combination treatment with trabectedin and irinotecan or topotecan has synergistic effects against ovarian clear cell carcinoma cells.

artículo científico publicado en 2014

Direct oral anticoagulants are effective and safe for the treatment of venous thromboembolism associated with gynecological cancers

scientific article published on 29 August 2019

Dose-volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy

artículo científico publicado en 2016

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression

Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy.

artículo científico publicado en 2018

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene

artículo científico publicado en 2017

Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature

artículo científico

Efficacy of raloxifene hydrochloride for the prevention of health care problems in patients who undergo surgery for endometrial cancer: a multicenter randomized clinical trial

artículo científico publicado en 2015

Estrogen stimulates female cancer progression by inducing myeloid-derived suppressive cells: investigations on pregnant and non-pregnant experimental models

scientific article published on 08 March 2019

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

article by Akihiko Yoshimura et al published 5 November 2018 in BMC Cancer

Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

artículo científico publicado en 2016

Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells

artículo científico publicado en 2009

IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment

artículo científico publicado en 2015

In vitro and in vivo assays to analyze the contribution of Rho kinase in angiogenesis

artículo científico publicado en 2008

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer

artículo científico publicado en 2017

Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer

artículo científico publicado en 2015

Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer

scientific article published on 30 October 2018

Oncological and Reproductive Outcomes of Abdominal Radical Trachelectomy

artículo científico publicado en 2020

Optimal timing for drainage of infected lymphocysts after lymphadenectomy for gynecologic cancer.

artículo científico publicado en 2015

PM01183 inhibits myeloid-derived suppressor cells in vitro and in vivo

artículo científico publicado en 2017

Perioperative venous thromboembolism in patients with gynecological malignancies: a lesson from four years of recent clinical experience

artículo científico publicado en 2014

Peripheral quantitative computed tomography is useful to monitor response to alendronate therapy in postmenopausal women

artículo científico publicado en 2009

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination

artículo científico publicado en 2017

Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary ⬇️

artículo científico publicado el 24 de abril de 2013

Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary

artículo científico publicado en 2014

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

artículo científico publicado en 2016

Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 cases

artículo científico publicado en 2017

Prenatal diagnosis of fetal intracranial hemorrhage in pregnancy complicated by idiopathic thrombocytopenic purpura

artículo científico publicado en 2010

Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study.

artículo científico publicado en 2015

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer

artículo científico publicado en 2018

Pseudomyxoma peritonei originating from colorectal cancer during pregnancy

artículo científico publicado en 2010

Pure Primary Ovarian Squamous Cell Carcinoma Perforating the Rectum.

artículo científico publicado en 2017

Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target

artículo científico publicado en 2019

Single-dose intra-arterial neoadjuvant chemotherapy while waiting for radical hysterectomy for stage IB-IIB cervical cancer

artículo científico publicado en 2016

Targeting Inhibitor of κB Kinase β Prevents Inflammation-Induced Preterm Delivery by Inhibiting IL-6 Production from Amniotic Cells

artículo científico publicado en 2016

Targeting interleukin-6 receptor inhibits preterm delivery induced by inflammation ⬇️

artículo científico publicado el 22 de agosto de 2013

The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary ⬇️

artículo científico publicado el 27 de mayo de 2011

The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations

artículo científico publicado en 2018

The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice

artículo científico publicado en 2016

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.

artículo científico publicado en 2015

The role of microRNAs in ovarian cancer

artículo científico publicado en 2014

The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations

artículo científico publicado en 2019

The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer

artículo científico publicado en 2020

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

artículo científico publicado en 2015

The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancer.

artículo científico publicado en 2015

The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy.

artículo científico publicado en 2017

Up-regulation of alpha5-integrin by E-cadherin loss in hypoxia and its key role in the migration of extravillous trophoblast cells during early implantation

artículo científico publicado en 2009

Usefulness of duloxetine for Paclitaxel-induced peripheral neuropathy treatment in gynecological cancer patients

artículo científico publicado en 2015

Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature

artículo científico publicado en 2014

Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary ⬇️

artículo científico publicado el 27 de julio de 2010

mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary

artículo científico publicado en 2009

miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression

artículo científico publicado en 2013

Lista de obras de

A 3-year follow-up study of radiotherapy using computed tomography-based image-guided brachytherapy for cervical cancer

A case of complete hydatidiform mole with coexistent fetus: conclusive diagnosis of androgenesis of the molar placenta by variation of paternal acrocentric short arms

A case of laparoscopic surgery for endometrial cancer in a patient previously treated with a transvaginal mesh procedure for pelvic organ prolapse

A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)

A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy

Balloon tamponade during cesarean section is useful for severe post‐partum hemorrhage due to placenta previa ⬇️

Cervical insufficiency following cesarean delivery after prolonged second stage of labor: experiences of two cases

Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).

Combination treatment with trabectedin and irinotecan or topotecan has synergistic effects against ovarian clear cell carcinoma cells.

Direct oral anticoagulants are effective and safe for the treatment of venous thromboembolism associated with gynecological cancers

Dose-volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression

Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy.

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene

Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature

Efficacy of raloxifene hydrochloride for the prevention of health care problems in patients who undergo surgery for endometrial cancer: a multicenter randomized clinical trial

Estrogen stimulates female cancer progression by inducing myeloid-derived suppressive cells: investigations on pregnant and non-pregnant experimental models

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells

IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment

In vitro and in vivo assays to analyze the contribution of Rho kinase in angiogenesis

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer

Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer

Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer

Oncological and Reproductive Outcomes of Abdominal Radical Trachelectomy

Optimal timing for drainage of infected lymphocysts after lymphadenectomy for gynecologic cancer.

PM01183 inhibits myeloid-derived suppressor cells in vitro and in vivo

Perioperative venous thromboembolism in patients with gynecological malignancies: a lesson from four years of recent clinical experience

Peripheral quantitative computed tomography is useful to monitor response to alendronate therapy in postmenopausal women

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination

Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary ⬇️

Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 cases

Prenatal diagnosis of fetal intracranial hemorrhage in pregnancy complicated by idiopathic thrombocytopenic purpura

Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study.

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer

Pseudomyxoma peritonei originating from colorectal cancer during pregnancy

Pure Primary Ovarian Squamous Cell Carcinoma Perforating the Rectum.

Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target

Single-dose intra-arterial neoadjuvant chemotherapy while waiting for radical hysterectomy for stage IB-IIB cervical cancer

Targeting Inhibitor of κB Kinase β Prevents Inflammation-Induced Preterm Delivery by Inhibiting IL-6 Production from Amniotic Cells

Targeting interleukin-6 receptor inhibits preterm delivery induced by inflammation ⬇️

The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary ⬇️

The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations

The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.

The role of microRNAs in ovarian cancer

The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations

The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancer.

The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy.

Up-regulation of alpha5-integrin by E-cadherin loss in hypoxia and its key role in the migration of extravillous trophoblast cells during early implantation

Usefulness of duloxetine for Paclitaxel-induced peripheral neuropathy treatment in gynecological cancer patients

Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature

Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary ⬇️

mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary

miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression